B. Antón

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer

A. Fernández-Santander, A. Romero-Lorca, A. Novillo, 2021, Pharmacogenomics and personalized medicine.

Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports

A. Fernández-Santander, A. Romero-Lorca, A. Novillo, 2020, World journal of gastroenterology.

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer

A. Fernández-Santander, A. Romero-Lorca, A. Novillo, 2022, Pharmaceutics.

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment

A. Fernández-Santander, A. Romero-Lorca, A. Novillo, 2023, Cancers.

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer

A. Fernández-Santander, A. Romero-Lorca, A. Novillo, 2021, International journal of molecular sciences.